Original Source(s)
Related Content
ApoB Goal Cost-Effective in Primary Prevention
Strategy increased quality-adjusted life-years and showed favorable cost-effectiveness vs low-density lipoprotein cholesterol and non–high-density lipoprotein cholesterol goals
April 15, 2026
-
4 min
Reduced-Dose Radiation Shows Durable Control
Single-arm cohort findings contrast with interim results from NRG-HN005, underscoring ongoing uncertainty around treatment deintensification.
May 8, 2026
-
4 min
Why FDA Said No to a Melanoma Drug
Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.
by Arthur Allen
May 15, 2026
-
9 min
